心理健康预防与促进干预的成本效果:经济学评价系统综述
该研究更新了既往两项综述,检索2008至2020年心理健康预防与促进干预的成本效果研究,共纳入65项完整经济学评价。多数研究一致发现此类干预具有成本效果或节省成本,但研究方法异质性大,中低收入国家证据有限。
要点
- 多数心理健康预防与促进干预具有成本效果或节省成本。
- 针对性预防比普遍性预防更可能具有成本效果。
- 儿童青少年中筛查联合心理干预(如CBT)最具成本效果。
核心结论
- 多数心理健康预防与促进干预研究显示具有成本效果或节省成本。
- 经济评价的质量与方法异质性限制成本效果结论的推广性。
- 中低收入国家心理健康干预的成本效果研究仍亟需开展。
研究设计与样本
- 系统综述更新了既往两项心理健康预防与促进成本效果综述。
- 检索2008至2020年电子数据库(含MEDLINE、PsycINFO、CINAHL、EconLit、Embase)的经济学评价研究。
- 共纳入65项完整经济学评价,其中23项针对儿童青少年、35项针对成人、其余针对老年人。
- 使用QHES工具评估研究质量,方案在PROSPERO注册(CRD42019127778)。
主要发现
- 多数研究一致发现心理健康预防与促进干预具有成本效果或节省成本。
- 针对性预防相比普遍性预防更可能具有成本效果。
- 儿童青少年中筛查联合心理干预(如CBT)是最具成本效果的预防干预。
- 育儿干预与工作场所干预在心理健康促进方面证据良好。
- 老年人预防或促进干预的证据尚不确定。
关键数值与推荐
- 主要结局为所有研究的增量成本效果比(ICER)或投资回报率(ROI)。
- 针对性预防相比普遍性预防更可能具有成本效果。
- 儿童青少年中筛查联合心理干预(如CBT)是最具成本效果的预防干预。
- 育儿干预与工作场所干预在心理健康促进方面证据良好。
- 老年人预防或促进干预的证据尚不确定。
临床怎么用
- 优先在儿童青少年中采用筛查联合心理干预(如CBT)预防精神障碍。
- 心理健康促进可考虑育儿干预与工作场所干预。
- 针对性预防策略比普遍性预防更具成本效果优势。
局限性
- 纳入经济评价设计异质性高,限制成本效果结论的推广性。
- 中低收入国家证据有限。
- 综述仅纳入心理健康为主要结局的研究,可能遗漏一般健康促进策略。
- 部分ROI研究可能因发表于灰色文献而未被纳入。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The prevention of mental disorders and promotion of mental health and well-being are growing fields. Whether mental health promotion and prevention interventions provide value for money in children, adolescents, adults, and older adults is unclear. The aim of the current study is to update 2 existing reviews of cost-effectiveness studies in this field in order to determine whether such interventions are cost-effective. METHODS AND FINDINGS: Electronic databases (including MEDLINE, PsycINFO, CINAHL, and EconLit through EBSCO and Embase) were searched for published cost-effectiveness studies of prevention of mental disorders and promotion of mental health and well-being from 2008 to 2020. The quality of studies was assessed using the Quality of Health Economic Studies Instrument (QHES). The protocol was registered with PROSPERO (# CRD42019127778). The primary outcomes were incremental cost-effectiveness ratio (ICER) or return on investment (ROI) ratio across all studies. A total of 65 studies met the inclusion criteria of a full economic evaluation, of which, 23 targeted children and adolescents, 35 targeted adults, while the remaining targeted older adults. A large number of studies focused on prevention of depression and/or anxiety disorders, followed by promotion of mental health and well-being and other mental disorders. Although there was high heterogeneity in terms of the design among included economic evaluations, most studies consistently found that interventions for mental health prevention and promotion were cost-effective or cost saving. The review found that targeted prevention was likely to be cost-effective compared to universal prevention. Screening plus psychological interventions (e.g., cognitive behavioural therapy [CBT]) at school were the most cost-effective interventions for prevention of mental disorders in children and adolescents, while parenting interventions and workplace interventions had good evidence in mental health promotion. There is inconclusive evidence for preventive interventions for mental disorders or mental health promotion in older adults. While studies were of general high quality, there was limited evidence available from low- and middle-income countries. The review was limited to studies where mental health was the primary outcome and may have missed general health promoting strategies that could also prevent mental disorder or promote mental health. Some ROI studies might not be included given that these studies are commonly published in grey literature rather than in the academic literature. CONCLUSIONS: Our review found a significant growth of economic evaluations in prevention of mental disorders or promotion of mental health and well-being over the last 10 years. Although several interventions for mental health prevention and promotion provide good value for money, the varied quality as well as methodologies used in economic evaluations limit the generalisability of conclusions about cost-effectiveness. However, the finding that the majority of studies especially in children, adolescents, and adults demonstrated good value for money is promising. Research on cost-effectiveness in low-middle income settings is required. TRIAL REGISTRATION: PROSPERO registration number: CRD42019127778.
引用
- Le LK, Esturas AC, Mihalopoulos C, et al. Cost-effectiveness evidence of mental health prevention and promotion interventions: A systematic review of economic evaluations. PLoS Med. 2021. PMID: 33974641. doi:10.1371/journal.pmed.1003606
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。